Lipocalin 2 Reduces MET Levels by Inhibiting MEK/ERK Signaling to Inhibit Nasopharyngeal Carcinoma Cell Migration

SIMPLE SUMMARY: Lipocalin-2 (LCN2) participates in multiple cellular processes, such as proliferation, survival, migration, invasion and inflammation. However, the molecular mechanisms involved in the LCN2-mediated cancer metastasis of human nasopharyngeal carcinoma remain poorly understood. Our stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ju-Pi, Lin, Chiao-Wen, Huang, Cheng-Chen, Lu, Yen-Ting, Ho, Yu-Ting, Yang, Shun-Fa, Hsin, Chung-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688489/
https://www.ncbi.nlm.nih.gov/pubmed/36428800
http://dx.doi.org/10.3390/cancers14225707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688489/
https://www.ncbi.nlm.nih.gov/pubmed/36428800
http://dx.doi.org/10.3390/cancers14225707

Ejemplares similares